News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
868,701 Results
Type
Article (87702)
Company Profile (747)
Press Release (780231)
Multimedia
Podcasts (197)
Webinars (28)
Section
Business (233162)
Career Advice (4144)
Deals (39884)
Drug Delivery (146)
Drug Development (91333)
Employer Resources (205)
FDA (18338)
Job Trends (17428)
News (397604)
Policy (39895)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3010)
Academic (1)
Accelerated approval (32)
Adcomms (31)
Allergies (144)
Alliances (56965)
ALS (179)
Alzheimer's disease (1795)
Antibody-drug conjugate (ADC) (341)
Approvals (18543)
Artificial intelligence (594)
Autoimmune disease (165)
Automation (38)
Bankruptcy (402)
Best Places to Work (12619)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (458)
Bladder cancer (156)
Brain cancer (64)
Breast cancer (656)
Cancer (4968)
Cardiovascular disease (426)
Career advice (3570)
Career pathing (41)
CAR-T (308)
CDC (47)
Celiac Disease (2)
Cell therapy (820)
Cervical cancer (35)
Clinical research (76977)
Collaboration (1846)
Company closure (4)
Compensation (1161)
Complete response letters (70)
COVID-19 (2983)
CRISPR (99)
C-suite (886)
Cystic fibrosis (154)
Data (6311)
Decentralized trials (2)
Denatured (73)
Depression (150)
Diabetes (495)
Diagnostics (7226)
Digital health (45)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (283)
Drug pricing (187)
Drug shortages (24)
Duchenne muscular dystrophy (238)
Earnings (100010)
Editorial (61)
Employer branding (25)
Employer resources (174)
Events (134965)
Executive appointments (1027)
FDA (21521)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1544)
Gene editing (217)
Generative AI (56)
Gene therapy (668)
GLP-1 (1057)
Government (5370)
Grass and pollen (8)
Guidances (383)
Healthcare (20901)
HIV (56)
Huntington's disease (50)
IgA nephropathy (85)
Immunology and inflammation (287)
Immuno-oncology (64)
Indications (103)
Infectious disease (3251)
Inflammatory bowel disease (207)
Inflation Reduction Act (15)
Influenza (118)
Intellectual property (251)
Interviews (816)
IPO (17948)
IRA (49)
Job creations (5200)
Job search strategy (2866)
JPM (68)
Kidney cancer (16)
Labor market (93)
Layoffs (649)
Leadership (39)
Legal (10130)
Liver cancer (97)
Longevity (14)
Lung cancer (666)
Lymphoma (377)
Machine learning (44)
Management (66)
Manufacturing (830)
MASH (173)
Medical device (14995)
Medtech (15048)
Mergers & acquisitions (22970)
Metabolic disorders (1314)
Multiple sclerosis (167)
NASH (23)
Neurodegenerative disease (355)
Neuropsychiatric disorders (96)
Neuroscience (3113)
Neurotech (1)
NextGen: Class of 2026 (7692)
Non-profit (5107)
Now hiring (66)
Obesity (611)
Opinion (332)
Ovarian cancer (166)
Pain (209)
Pancreatic cancer (234)
Parkinson's disease (297)
Partnered (37)
Patents (510)
Patient recruitment (497)
Peanut (60)
People (66885)
Pharmaceutical (135)
Pharmacy benefit managers (26)
Phase 1 (23804)
Phase 2 (33444)
Phase 3 (25147)
Pipeline (5237)
Policy (301)
Postmarket research (3548)
Preclinical (10685)
Press Release (72)
Prostate cancer (245)
Psychedelics (56)
Radiopharmaceuticals (302)
Rare diseases (913)
Real estate (7442)
Recruiting (81)
Regulatory (28981)
Reports (67)
Research institute (2723)
Resumes & cover letters (651)
Rett syndrome (28)
RNA editing (21)
RSV (76)
Schizophrenia (160)
Series A (261)
Series B (199)
Service/supplier (27)
Sickle cell disease (102)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (47)
Startups (4332)
State (2)
Stomach cancer (18)
Supply chain (100)
Tariffs (87)
The Weekly (122)
Vaccines (1110)
Venture capital (96)
Weight loss (411)
Women's health (91)
Worklife (22)
Date
Today (136)
Last 7 days (633)
Last 30 days (2266)
Last 365 days (31374)
2026 (3187)
2025 (31720)
2024 (37476)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (91)
Alaska (7)
Arizona (334)
Arkansas (14)
Asia (51574)
Australia (9059)
California (11547)
Canada (3279)
China (1182)
Colorado (477)
Connecticut (488)
Delaware (342)
Europe (118389)
Florida (1679)
Georgia (347)
Hawaii (4)
Idaho (67)
Illinois (906)
India (70)
Indiana (542)
Iowa (24)
Japan (437)
Kansas (133)
Kentucky (39)
Louisiana (28)
Maine (82)
Maryland (1440)
Massachusetts (8545)
Michigan (345)
Minnesota (653)
Mississippi (6)
Missouri (140)
Montana (34)
Nebraska (29)
Nevada (126)
New Hampshire (85)
New Jersey (3078)
New Mexico (32)
New York (3002)
North Carolina (1607)
North Dakota (10)
Northern California (5552)
Ohio (348)
Oklahoma (20)
Oregon (53)
Pennsylvania (2279)
Puerto Rico (23)
Rhode Island (50)
South America (1662)
South Carolina (67)
South Dakota (1)
Southern California (4478)
Tennessee (162)
Texas (1796)
United States (41337)
Utah (347)
Vermont (1)
Virginia (283)
Washington D.C. (78)
Washington State (962)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
868,701 Results for "lotus bio technologies development corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SL BIO Ltd. and Horizon Space Acquisition II Corp. Announce Registration Statement Effectiveness and Extraordinary General Meeting Date to Approve Business Combination
January 15, 2026
·
8 min read
Press Releases
Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
January 21, 2026
·
7 min read
Press Releases
Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock
January 23, 2026
·
6 min read
Press Releases
Scryb Inc. Provides Early Warning Update on Holdings in Cybeats Technologies Corp.
January 15, 2026
·
5 min read
Press Releases
BioSig Technologies, Inc. Announces Corporate Rebrand to Streamex Corp.
September 11, 2025
·
3 min read
Biotech Beach
Lotus Bio-Technology Development Corp, Inc. Initiates Company Name Change
Lotus Bio-Technology Development Corp. (OTC:LBTD) is excited to announce today that the company has begun the process of changing its name from Lotus Bio-Technology Development Corp. to Boomerang Corporation.
August 16, 2022
·
2 min read
Press Releases
Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic
January 21, 2026
·
6 min read
Press Releases
Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments
November 10, 2025
·
17 min read
Press Releases
Sharp Therapeutics Corp. Reports Third Quarter 2025 Results and Development Update
November 26, 2025
·
3 min read
Press Releases
Instil Bio’s Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco
January 6, 2026
·
2 min read
1 of 86,871
Next
